Teva Pharmaceutical Industries ADR(TEVA-N)NYSE
Today's Change
Real-Time Last Update
Pre Market Change
Pre Market Last Update
Volume
Current Target Price
High Target Price
Mean Target Price
Low Target Price
Median Target Price
Earnings Estimates
| Current Qtr12/2024 | Next Qtr03/2025 | Fiscal Yr12/2024 | Fiscal Yr12/2025 | |
|---|---|---|---|---|
| Average Estimate | 0.66 | 0.48 | 2.34 | 2.64 |
| Number of Estimates | 5 | 2 | 5 | 5 |
| High Estimate | 0.68 | 0.50 | 2.36 | 2.98 |
| Low Estimate | 0.65 | 0.46 | 2.30 | 2.52 |
| Prior Year | 0.98 | 0.46 | 2.46 | 2.34 |
| Growth Rate Est. (year over year) | -32.65% | +4.35% | -4.88% | +12.82% |
Earnings History - Surprises*
| Qtr Ending09/2024 | Qtr Ending06/2024 | Qtr Ending03/2024 | Qtr Ending12/2023 | |
|---|---|---|---|---|
| Reported | $0.67 | $0.58 | $0.46 | $0.98 |
| Estimate | $0.63 | $0.55 | $0.49 | $0.73 |
| Difference | +0.04 | +0.03 | -0.03 | +0.25 |
| Surprise | +6.35% | +5.45% | -6.12% | +34.25% |
* Earnings are based on GAAP income from continuing operations.
Average Analyst Ratings
Rating
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell
# of Analysts
4.56
3 Mths Ago9
4.75
2 Mths Ago8
4.75
1 Mth Ago8
4.75
Current8
Ratings Values:
Strong Buy5
Moderate Buy4
Hold3
Moderate Sell2
Strong Sell1
Ratings Breakdown
| 3 Mths Ago | 2 Mths Ago | 1 Mth Ago | Current | |
|---|---|---|---|---|
| # of Analysts: | 9 | 8 | 8 | 8 |
7 | 7 | 7 | 7 | |
| Holds | 2 | 1 | 1 | 1 |
Key:
Strong Buy
Moderate Buy
Hold
Moderate Sell
Strong Sell